Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4078695, 8 pages
http://dx.doi.org/10.1155/2016/4078695
Research Article

Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy

Geriatrics Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Section XVI, Delegación Tlalpan, 14000 Mexico, DF, Mexico

Received 28 June 2015; Revised 31 August 2015; Accepted 19 October 2015

Academic Editor: Dan Ziegler

Copyright © 2016 Alberto Mimenza Alvarado and Sara Aguilar Navarro. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Johannsen, T. Smith, A. M. Havasger et al., “Evaluation of patients with symptoms suggestive of chronic polyneuropathy,” Journal of Clinical Neuromuscular Disease, vol. 3, no. 2, pp. 47–52, 2001. View at Publisher · View at Google Scholar
  2. R. E. Maser, A. R. Steenkiste, J. S. Dorman et al., “Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study,” Diabetes, vol. 38, no. 11, pp. 1456–1461, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Gilron, T. S. Jensen, and A. H. Dickenson, “Combination pharmacotherapy for management of chronic pain: From bench to bedside,” The Lancet Neurology, vol. 12, no. 11, pp. 1084–1095, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Berger, A. Sadosky, E. Dukes, J. Edelsberg, and G. Oster, “Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study,” BMC Neurology, vol. 12, article 8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mimenza and S. Aguilar, “Comparative clinical trial of safety and tolerability of gabapentin plus vitamin B1/B12 versus pregabalin in the treatment of painful peripheral diabetic neuropathy,” Journal of Pain & Relief, vol. 3, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  6. G. Reyes-García, N. L. Caram-Salas, R. Medina-Santillán, and V. Granados-Soto, “Oral administration of B vitamins increases the antiallodynic effect of gabapentin in the rat,” Proceedings of the Western Pharmacology Society, vol. 47, pp. 76–79, 2004. View at Google Scholar · View at Scopus
  7. T. Várkonyi and P. Kempler, “Diabetic neuropathy: new strategies for treatment,” Diabetes, Obesity and Metabolism, vol. 10, no. 2, pp. 99–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. L. Vesely, “B complex vitamins activate rat guanylate cyclase and increase cyclic GMP levels,” European Journal of Clinical Investigation, vol. 15, no. 5, pp. 258–262, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Backonja, A. Beydoun, K. R. Edwards et al., “Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial,” The Journal of the American Medical Association, vol. 280, no. 21, pp. 1831–1836, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Freeman, E. Durso-DeCruz, and B. Emir, “Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses,” Diabetes Care, vol. 31, no. 7, pp. 1448–1454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Bennett, “The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs,” Pain, vol. 92, no. 1-2, pp. 147–157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. E. C. Huskisson, “Measurement of pain,” The Lancet, vol. 304, no. 7889, pp. 1127–1131, 1974. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Guy, ECDEU Assessment Manual for Psychopharmacology, Psychopharmacology Research Branch, Division of Extramural Research Programs, US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Rockville, Md, USA, 1976.
  14. H. Hurst and J. Bolton, “Assessing the clinical significance of change scores recorded on subjective outcome measures,” Journal of Manipulative and Physiological Therapeutics, vol. 27, no. 1, pp. 26–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. W. Johns, “A new method for measuring daytime sleepiness: the Epworth sleepiness scale,” Sleep, vol. 14, no. 6, pp. 540–545, 1991. View at Google Scholar · View at Scopus
  16. K. C. Gorson, C. Schott, R. Herman, A. H. Ropper, and W. M. Rand, “Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 66, no. 2, pp. 251–252, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. Gómez-Pérez, A. Perez-Monteverde, O. Nascimento et al., “Gabapentin for the treatment of painful diabetic neuropathy: dosing to achieve optimal clinical response,” British Journal of Diabetes and Vascular Disease, vol. 4, no. 3, pp. 173–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Backonja and R. L. Glanzman, “Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials,” Clinical Therapeutics, vol. 25, no. 1, pp. 81–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. D. Ang, M. J. M. Alviar, A. L. Dans, and et al, “Vitamin B for treating peripheral neuropathy,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD004573, 2008. View at Publisher · View at Google Scholar
  20. T. Mixcoatl-Zecuatl, G. N. Quiñónez-Bastidas, N. L. Caram-Salas et al., “Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 6, pp. 431–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Jermendy, “Evaluating thiamine deficiency in patients with diabetes,” Diabetes and Vascular Disease Research, vol. 3, no. 2, pp. 120–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Reyes-García, R. Medina-Santillán, H. I. Rocha-González, and V. Granados-Soto, “Synergistic interaction between spinal gabapentin and oral B vitamins in a neuropathic pain model,” Proceedings of the Western Pharmacology Society, vol. 46, pp. 91–94, 2003. View at Google Scholar · View at Scopus
  23. Z.-B. Wang, Q. Gan, R. L. Rupert, Y.-M. Zeng, and X.-J. Song, “Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury,” Pain, vol. 114, no. 1-2, pp. 266–277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. M. Cohen, L. A. Menefee, K. Doghramji, W. R. Anderson, and E. D. Frank, “Sleep in chronic pain: problems and treatments,” International Review of Psychiatry, vol. 12, no. 2, pp. 115–116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-S. Lo, C.-M. Yang, H. G. Lo, C.-Y. Lee, H. Ting, and B.-S. Tzang, “Treatment effects of gabapentin for primary insomnia,” Clinical Neuropharmacology, vol. 33, no. 2, pp. 84–90, 2010. View at Publisher · View at Google Scholar · View at Scopus